Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study

Table 1

Tumor volume reduction from PET-1 to PET-2 (expressed as percentage) in single-dose group (SDG) and multiple-dose group (MDG), respectively.

Mouse	SDG (%)	MDG (%)
1	93	78
2	O	X
3	91	71
4	86	64
5	X	69
6	68	92
7	O	X
8	80	O
9	73	73
10	70	X
11	X	X
12	84	X
13	91	80
14	X	O
15	68	88
16	73	75
17	79	84
18	84	X
19	72	69
20	X	X
21	88	92
22	90	X
23	72	O
24	X	88
25	94	X
26	X	O
27	X	76
28	77	75
29	75	82
30	X	90

X = mouse deceased; O = tumor disappearance.